| Catalogue number: | PA PEP 001539 | 
| Chemical name: | Lorvotuzumab mertansine | 
| CAS Number: | 1008106-64-6 | 
| Category: | peptides,Antibody Drug Conjugate | 
| Synonyms: | NA | 
| Molecular form: | NA | 
| Appearance: | NA | 
| Mol. Weight: | NA | 
| Storage: | 2-8°C Refrigerator | 
| Shipping Conditions: | Ambient | 
| Applications: | Lorvotuzumab mertansine is an ADC consisting of a humanized N901 monoclonal antibody against CD56 bound to maytansinoid DM1 via a stable disulfide linker. Lorvotuzumab mertansine has antitumor activity | 
Lorvotuzumab mertansine
Related Products
Search by Keywords – Buy 1008106-64-6 | Purchase 1008106-64-6 | Order 1008106-64-6 | Enquire 1008106-64-6 | Price of 1008106-64-6 | 1008106-64-6 Cost | 1008106-64-6 Supplier | 1008106-64-6 Distributor | 1008106-64-6 Manufacturer | 1008106-64-6 Exporter


 
		
			 
		 
		     
	
		![4-Tert-butyl n-[(tert-butoxy)carbonyl]-l-aspartate dicyclohexylamine s 1913-12-8](https://www.pharmaffiliates.com/pimages/PAPEP000500.jpg) 
		 
		 
		 
		 
		 
		 
		 
 
 
